Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Noemi Tapiador"'
Autor:
Ernesto Marín, Alicia Rodríguez, Miguel A. Rico, Jesús Montilla, David Vazquez, Jesús Vaquero, Francisco Morán Martínez, Coral García, Marta V. Fernández, Mercedes Zurita, Salvador Bustamante, Carlos Morejón, Concepción Aguayo, Joaquín Carballido, Marta Sevilla, Paula Martínez, Celia Bonilla, Noemi Tapiador, Cecilia Fernandez, Mercedes Ovejero
Publikováno v:
Cytotherapy. 19:349-359
Background aims Cell therapy with mesenchymal stromal cells (MSCs) offers new hope for patients suffering from spinal cord injury (SCI). Methods Ten patients with established incomplete SCI received four subarachnoid administrations of 30 × 10 6 aut
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::09421a4552653360abf2e0991f317e1b
https://doi.org/10.1016/j.jcyt.2016.12.002
https://doi.org/10.1016/j.jcyt.2016.12.002
Autor:
María Jesús Antón, Montserrat Molina, José Gabriel Pérez, Santiago Pina, Noemí Tapiador, Beatriz De La Calle, Mónica Martínez, Paula Ortega, María Belén Ruspaggiari, Consuelo Tudela, Marta Conejo, Pedro Leno, Marta López, Carmen Marhuenda, Carlos Arias-Cabrales, Pascal Maisonobe, Alberto Herrera, Ernesto Candau
Publikováno v:
Toxins, Vol 16, Iss 8, p 340 (2024)
We conducted a multicenter and retrospective study to describe the use of botulinum toxin type A (BoNT-A) to treat post-stroke spasticity (PSS). Data were extracted from free-text in electronic health records (EHRs) in five Spanish hospitals. We incl
Externí odkaz:
https://doaj.org/article/bc934ed1a4404e3db510e5e244c77525
Autor:
Héctor Guadalajara, Concepción Aguayo, Miguel A. Rico, Miguel Leon, Ernesto Marín, Ignacio Valverde, Damián García-Olmo, David Vazquez, Joaquín Carballido, Gregorio Rodríguez-Boto, Marta Sevilla, Noemi Tapiador, Mercedes Zurita, Cecilia Fernandez, Jesús Vaquero
Publikováno v:
Cytotherapy. 20(6)
Background aims Recently, clinical studies show that cell therapy with mesenchymal stromal cells (MSCs) improves the sequelae chronically established in paraplegic patients, being necessary to know which of them can obtain better benefit. Methods We
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2c7e885ce752d7cdb252d234c82b601c
https://pubmed.ncbi.nlm.nih.gov/29784434
https://pubmed.ncbi.nlm.nih.gov/29784434
Autor:
Jesús Vaquero, Mercedes Zurita, Miguel A. Rico, Concepcion Aguayo, Celia Bonilla, Esperanza Marin, Noemi Tapiador, Marta Sevilla, David Vazquez, Joaquin Carballido, Cecilia Fernandez, Gregorio Rodriguez-Boto, Mercedes Ovejero, Concepción Aguayo, Alicia Rodríguez, Paula Martínez, Silvia de la Calle, Marta V. Fernández, Cecilia Fernández, Gregorio Rodríguez-Boto, Laura de Reina, Anwar Saab, Carlos Cotua, Xavier A. Santander, Raquel Gutiérrez, Cristóbal Saldaña, Rasha Hassan, Celia Ortega, Alicia Madrid, Montaña Mariscal, Esperanza Marín, Luis F. López, Alberto Pérez, Edwin E. Ebrat, Marta Vaquero, Mónica Martín, Isabel Mayoral, Dolores Canales, Joaquín Carballido, Rosario Serrano, Gertrudis Saucedo, Rafael Cabrera, Maria E. Martínez Begoña Pérez de Camino, Ana Alarcón, Daniel Naya, Rosalía Alonso, Jose R. Alamo, Irene Romera, Inmaculada Mourelle, Carmen Sánchez, Rocío Segovia, Alberto Gutiérrez, Verónica Guillo, Sara del Valle, Paula Rey, Jorge Mucientes, Begoña Rodríguez
Publikováno v:
Cytotherapy. 20(6)
Background aims Cell therapy with autologous mesenchymal stromal cells (MSCs) in patients with spinal cord injury (SCI) is beginning, and the search for its better clinical application is an urgent need. Methods We present a phase 2 clinical trial in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1c8ae0ba12f5ff6405dd6e1d93453bac
https://pubmed.ncbi.nlm.nih.gov/29853256
https://pubmed.ncbi.nlm.nih.gov/29853256